Comparative-effectiveness of pembrolizumab vs nivolumab for patients with metastatic melanoma

Moser, JC, Wei, G, Colonna, SV, Grossman, KF, Patel, SB, Hyngstrom, JR

January 2020

Manuscript

Acta Oncologia

Prognostic significance of cancer patient reported outcomes in cancer

Kerrigan, KC, Patel, SB, Halland, B, Ose, D, Chalmers, AW, Haydell, T, Meropol, NJ, Akerley, WL

January 2020

Manuscript

Journal of Oncology Practice

Flatiron-authored

First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis

Parikh, RB, Feld, EK, Galsky, MD, Adamson, BJS, Cohen, AB, Baxi, SS, Boursi, SB, Christodouleas, JP, Vaughn, DJ, Meropol, NJ, Mamtani, R

December 2019

Manuscript

Future Oncology

Flatiron-authored

December 2019

Abstract

San Antonio Breast Cancer Symposium

Initial real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+HER2-metastatic breast cancer

Carter, GC, Sheffield, KM, Gossai, A, Huang, Y, Zhu, YE, Bowman, L, Smyth, EN, Mathur, R, Cohen, AB, Baxi, SS, Rybowski, S, Chong, AL, Seidman, AD

December 2019

Abstract

San Antonio Breast Cancer Symposium

Flatiron-authored

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

San Antonio Breast Cancer Symposium

Visualization of the relationship between survival and sequential treatments in metastatic breast cancer

Rocque, GB, Gilbert, A, Williams, CP, Nakhmani, A, Kandhare, PG, Azuero, A, Bhatia, S, Kenzik, KM, Burkard, ME

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

San Antonio Breast Cancer Symposium

Overall survival for first-line palbociclib plus letrozole alone for HR+/HER2- metastatic breast cancer patients in US real-world clinical practice

DeMichele, A, Cristofanilli, M, Brufsky, A, Liu, X, Mardekian, J, McRoy, L, Layman, RM, Rugo, HS, Finn, RS

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2019

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2019

Abstract

American Society of Hematology Annual Meeting

December 2019

Abstract

American Society of Hematology Annual Meeting

December 2019

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2019

Abstract

American Society of Hematology Annual Meeting

December 2019

Abstract

American Society of Hematology Annual Meeting

December 2019

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2019

Abstract

American Society of Hematology Oncology

Challenges and opportunities to updating prescribing information for longstanding oncology drugs

Balogh, EP, Bindman, AB, Eckhardt, SG, Halabi, S, Harvey, RD, Jaiyesimi, I, Miksad, RA, Moses, HL, Nass, SJ, Schilsky, RL, Sun, S, Torrente, JM, Warren, KE

December 2019

Manuscript

The Oncologist

Flatiron-authored

November 2019

Abstract

EU ISPOR

A landmark response analysis to determine cost-effectiveness of third-line nivolumab for small cell lung cancer

Smare, C, Dave, K, Juarez-Garcia, A, Schoenherr, N, Abraham, P, Penrod, JR, Camidge, DR, Yuan, Y

November 2019

Abstract

EU ISPOR

A partitioned survival model to determine cost-effectiveness of third-line nivolumab monotherapy for small cell lung cancer

Smare, C, Dave, K, Juarez-Garcia, A, Schoenherr, N, Abraham, P, Penrod, JR, Camidge, DR, Yuan, Y

November 2019

Abstract

EU ISPOR

November 2019

Abstract

EU ISPOR

November 2019

Manuscript

Cancer Medicine

October 2019

Abstract

AMCP Nexus

October 2019

Abstract

AMCP Nexus

Medicaid expansion and racial inequities in next-generation sequencing testing in oncology

Hooley, IJ, Cohen, AB, Gross, CP, Williams, ER, Adamson, BJS

October 2019

Abstract

Applying Big Data to Address the Social Determinants of Health in Oncology

Flatiron-authored

Technology-enabled clinical trials: Transforming medical evidence generation

Marquis-Gravel, G, Roe, MT, Turakhia, MP, Boden, W, Temple, R, Sharma, A, Hirshberg, B, Slater, P, Craft, N, Stockbridge, N, McDowell, B, Waldstreicher, J, Bourla, AB, Bansilal, S, Wong, JL, Meunier, C, Kassahun, H, Coran, P, Bataille, L, Patrick-Lake, B, Hirsch, BR, Reites, J, Mehta, R, Muse, ED, Chandross, KJ, Silverstein, JC, Silcox, C, Overhage, JM, Califf, RM, Peterson, ED

October 2019

Manuscript

Circulation

Flatiron-authored

October 2019

Abstract

Asian Conference on Pharmacoepidemiology

Comparative-effectiveness of pembrolizumab vs nivolumab for patients with metastatic melanoma

Moser, JC, Wei, G, Colonna, SV, Grossman, KF, Patel, SB, Hyngstrom, JR

October 2019

Abstract

ESMO Annual Congress

October 2019

Abstract

ESMO Annual Congress

Brain metastases, treatment patterns, and outcomes in ROS1-positive NSCLC patients from US oncology community centers

Krebs, MG, Perez, L, Surinach, A, Doebele, RC, Martina, R, Martinec, M, Riehl, T, Meropol, NJ, Wong, WB, Crane, G

October 2019

Abstract

ESMO Annual Congress

Flatiron-authored

Biomarker status as a mediator of age-related overall survival (OS) in advanced non-small cell lung cancer (aNSCLC)

Cohen, AB, Neri, B, Adamson, BJS, Scanlon, CM, Gross, CP, Meropol, NJ, Miksad, RA

October 2019

Abstract

ESMO Annual Congress

Flatiron-authored

September 2019

Abstract

ESMO Annual Congress

September 2019

Abstract

ESMO Annual Congress

September 2019

Abstract

ESMO Annual Congress

Co-occurrence of NTRK fusions with other genomic biomarkers in cancer patients

Jiao, X, Lokker, A, Snider, J, Castellanos, EH, Nanda, S, Fisher, V, Zong, J, Keating, K, Fellous, M

September 2019

Abstract

ESMO Annual Congress

Flatiron-authored

September 2019

Abstract

ESMO Annual Congress

Flatiron-authored

Prevalence and prognostic effect of high tumor mutation burden (TMB-H) across multiple less common solid cancers using a real-world dataset

Backenroth D, Shao C, Li G, Huang L,Pruitt SK, Castellanos EH, Frampton GM, Carson KR, Snow T, Singal G, Fabrizio D, Alexander BM, Jin FJ, Zhou W

September 2019

Abstract

ESMO Annual Congress

Flatiron-authored

September 2019

Abstract

ESMO Annual Congress

Flatiron-authored

Association between FDA label restriction and immunotherapy and chemotherapy use in bladder cancer

Parikh RB, Adamson BJS, Khozin S, Galsky MD, Baxi SS, Cohen A, Mamtani R

September 2019

Manuscript

JAMA

Flatiron-authored

Real-world treatment patterns and clinical outcomes across lines of therapy in patients with advanced/metastatic gastric or gastroesophageal junction cancer

Le, DT, Ott, PA, Korytowsky, B, Le, H, Le, TK, Zhang, Y, Maglinte, GA, Abraham, P, Patel, D, Shangguan, T, Chau, I

September 2019

Manuscript

Clinical Colorectal Cancer

Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer

Chau I, Le DT, Ott PA, Korytowsky B, Le H, Le TK, Zhang Y, Sanchez T, Maglinte GA, Laurie M, Abraham P, Patel D, Shangguan T

September 2019

Manuscript

Gastric Cancer

Real-world evidence of male breast cancer (BC) patients treated with palbociclib (PAL) in combination with endocrine therapy (ET)

Bartlett, CH, Mardekian, J, Yu-Kite, M, Cotter, MJ, Kim, S, Decembrino, J, Snow, T, Carson, KR, Rockland, JM, Kraus, AL, Wilner, KD, Oharu, N, Schnell, P, Lu, D, Tursi, J

September 2019

Abstract

Annual Metastatic Breast Cancer Conference

Flatiron-authored

Cost effectiveness of PD-L1-based test-and-treat strategy with pembrolizumab as the first-line treatment for metastatic NSCLC in Hong Kong

Loong HH, Wong CKH, Leung LKS, Dhankhar P, Insinga RP, Chandwani S, Hsu DC, Lee MYK, Huang M, Pellissier J, Rai A, Achra M, Tan SC

September 2019

Manuscript

Pharmacoeconomics Open

LKB1 mutations in metastatic non-small cell lung cancer (mNSCLC): Prognostic value in the real world

Golozar, A, Collins, J, Fraeman, K, Nordstrom, BL, McEwen, R, Shire, N, Higgs, B

September 2019

Abstract

World Conference on Lung Cancer